HBIMEDICAL ApS: Financial statements 2023
CVR: 36426063
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HBIMEDICAL ApS (CVR 36426063) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -63,416 and a net result of DKK -67,545 compared with DKK 36,261 the year before. Equity in the 2023 report amounted to DKK 137,499. The solvency ratio was 54.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -63,416
- Profit/Loss
- DKK -67,545
- Equity
- DKK 137,499
- Total Assets
- DKK 251,309
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -63 t. | -68 t. | 137 t. | 1 |
| 2022 | - | 39 t. | 36 t. | 205 t. | 1 |
| 2021 | - | 125 t. | 119 t. | 219 t. | 1 |
| 2020 | - | 83 t. | 78 t. | 100 t. | 1 |
| 2019 | - | 154 t. | 118 t. | 22 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HBIMEDICAL ApS has published its annual report for 2022. Gross profit came to DKK 38,949, and the net result was DKK 36,261.
About HBIMEDICAL ApS
HBIMEDICAL ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Hanne Busch Ibsen. The company is owned by Hanne Busch Ibsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -34,441 and a net result of DKK -34,479 compared with DKK 42,098 the year before. Equity in the 2025 report amounted to DKK 145,118.